93 research outputs found

    Analysis of the variation of in situ seafloor sediments acoustic characteristics with porosity based EDFM

    Get PDF
    Numerous factors influence the acoustic characteristics of seafloor sediments, necessitating a comprehensive study that combines theoretical analysis, laboratory measurements and in situ measurements to support acoustic prediction and inversion. In this study, a porosity-based effective density fluid model (P-EDFM) is established to analyze the variation of acoustic properties with the porosity of seafloor sediments. On the biases of P-EDFM, the attribute of measured sound velocity and acoustic attenuation coefficient of seafloor sediment in Series 9B of the SAX99 was well interpreted within the frequency range of 25-100 kHz. The in situ measured sound velocity ratio was well predicated by the P-EDFM in the East China Sea and Yellow Sea. It reveals that the in situ sound velocity ratio decreases with increasing bulk porosity and with decreasing bulk density. The scattering and differences in the acoustic attenuation coefficient measured in situ in seafloor sediments are found to be greater than those observed for sound velocity. After considering the influence of temperature in the P-EDFM, the prediction of in situ sound velocity aligns well with the measured dataset. While, the acoustic attenuation coefficient exhibits an inflection point, increasing initially and then decreasing with changes in porosity, similar to the observed pattern in Hamilton’s observation and estimation. By incorporating temperature and frequency influences, the in situ measurements of sound velocity of seafloor sediments are corrected into laboratory sound velocities by using the P-EDFM. The result reveals the sediment samples’ sampling and transmitting process has a much greater impact on the sound velocity of sandy sediment in the East China Sea compared to muddy sediment. Overall, P-EDFM can predict the in situ sound velocity and sound attenuation coefficient under different temperatures and frequencies, with a lower prediction error for sound velocity compared to sound attenuation coefficient

    Research Progress on Immunomodulatory Activity of Polysaccharides from Blue Foods

    Get PDF
    With the current over-exploitation of terrestrial resources, multi-dimensional in-depth utilization of aquatic resources has attracted widespread attention. Blue foods including marine animals and algae supply nutrients to 3.2 billion people around the world. Polysaccharides are an important class of nutritional components in “blue foods”, and have various biological activities such as antitumor, anti-inflammatory, and anti-allergic functions. The exertion of these physiological functions is closely related to their immunomodulatory activities. Therefore, this article reviews recent progress on the classification, composition and immunomodulatory activities of polysaccharides in blue foods with a focus on the regulatory effects of polysaccharides in marine mollusks and seaweeds on innate/adaptive immune responses, the antitumor effects of pro-inflammatory polysaccharides, and their role in immune adjuvants, and the role of anti-inflammatory polysaccharides in autoimmune diseases and inflammation in an effort to enrich the understanding of the different immune effects of marine polysaccharides and to provide theoretical support for the development of immunomodulatory functional foods based on polysaccharides from blue foods

    Time trends and heterogeneity in the disease burden of visual impairment due to cataract, 1990–2019: A global analysis

    Get PDF
    ObjectivesThis study aimed to estimate the disease burden of cataract and evaluate the contributions of risk factors to cataract-associated disability-adjusted life years (DALYs).Materials and methodsPrevalence and DALYs of visual impairment due to cataract were extracted from the Global Burden of Disease (GBD) study 2019 to explore time trends and annual changes. Regional and country-level socioeconomic indexes were obtained from open databases. The time trend of prevalence and DALYs was demonstrated. Stepwise multiple linear regression was used to evaluate associations between the age-standardized rate of DALYs of cataract and potential predictors.ResultsGlobal Prevalence rate of visual impairment due to cataract rose by 58.45% to 1,253.9 per 100,000 population (95% CI: 1,103.3 to 1,417.7 per 100,000 population) in 2019 and the DALYs rate rose by 32.18% from 65.3 per 100,000 population (95% CI: 46.4 to 88.2 per 100,000 population) in 1990 to 86.3 per 100,000 population (95% CI: 61.5 to 116.4 per 100,000 population) in 2019. Stepwise multiple linear regression model showed that higher refractive error prevalence (ÎČ = 0.036, 95% CI: 0.022, 0.050, P < 0.001), lower number of physicians per 10,000 population (ÎČ = −0.959, 95% CI: −1.685, −0.233, P = 0.010), and lower level of HDI (ÎČ = −134.93, 95% CI: −209.84, −60.02, P = 0.001) were associated with a higher disease burden of cataract.ConclusionSubstantial increases in the prevalence of visual impairment and DALYs of cataract were observed from 1990 to 2019. Successful global initiatives targeting improving cataract surgical rate and quality, especially in regions with lower socioeconomic status, is a prerequisite to combating this growing burden of cataract in the aging society

    Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves’ Orbitopathy

    Get PDF
    Aim. To study the efficacy and safety of subantimicrobial dose (SD) doxycycline(50 mg/d) in patients with active and moderate-to-severe Graves’ orbitopathy (GO). Methods. Thirteen patients with active and moderate-to-severe GO received once daily oral doxycycline (50 mg/d) for 12 wk. Treatment response at 24 wk was used as the primary outcome, measured by a composite of improvement in Clinical Activity Score (CAS), diplopia, motility, soft tissue swelling, proptosis, and eyelid aperture. Secondary outcome was the change of quality of life score (QoL, including visual functioning subscale and appearance subscale). Adverse events were also recorded. Results. Overall improvement was noted in eight out of 13 patients (61.5%, 95% CI 31.6%–86.1%). Both CAS and soft tissue swelling significantly ameliorated in eight patients at 24 wk. Five patients (38.5%) had improvement in ocular motility of ≄8 degrees. Eyelid aperture (46.2%) also decreased remarkably. For QoL, a significant improvement in appearance subscale (P=0.008) was noted during the study, whereas no difference was observed in visual functioning subscale (P=0.21). Two patients reported mild stomachache at 12 wk. Conclusions. SD doxycycline appears to be effective and safe for the treatment of active and moderate-to-severe GO. It might serve as a new promising therapeutic strategy for GO. This trial is registered with NCT01727973

    Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis

    Get PDF
    Background: Although it is widely known that hypertension is an important cause of chronic kidney disease (CKD), little detailed quantitative research exists on the burden of CKD due to hypertension.Objective: The objective of the study is to estimate the global disease burden of CKD due to hypertension and to evaluate the association between the socioeconomic factors and country-level disease burden of CKD due to hypertension.Methods: We extracted the disability-adjusted life-year (DALY) numbers, rates, and age-standardized rates of CKD due to hypertension from the Global Burden of Disease Study 2019 database to investigate the time trends of the burden of CKD due to hypertension from 1990 to 2019. Stepwise multiple linear regression analysis was performed to evaluate the correlations between the age-standardized DALY rate and socioeconomic factors and other related factors obtained from open databases.Results: Globally, from 1990 to 2019, DALY numbers caused by CKD due to hypertension increased by 125.2% [95% confidential interval (CI), 124.6 to 125.7%]. The DALY rate increased by 55.7% (55.3 to 56.0%) to 128.8 (110.9 to 149.2) per 100,000 population, while the age-standardized DALYs per 100,000 population increased by 10.9% (10.3 to 11.5%). In general, males and elderly people tended to have a higher disease burden. The distribution disparity in the burden of CKD due to hypertension varies greatly among countries. In the stepwise multiple linear regression model, inequality-adjusted human development index (IHDI) [ÎČ = −161.1 (95% CI −238.1 to −84.2), P < 0.001] and number of physicians per 10,000 people [ÎČ = −2.91 (95% CI −4.02 to −1.80), P < 0.001] were significantly negatively correlated with age-standardized DALY rate when adjusted for IHDI, health access and quality (HAQ), number of physicians per 10,000 people, and population with at least some secondary education.Conclusion: Improving the average achievements and equality of distribution in health, education, and income, as well as increasing the number of physicians per 10,000 people could help to reduce the burden of CKD due to hypertension. These findings may provide relevant information toward efforts to optimize health policies aimed at reducing the burden of CKD due to hypertension

    Arteriopathy diagnosis in childhood arterial ischemic stroke: results of the vascular effects of infection in pediatric stroke study.

    Get PDF
    Background and purposeAlthough arteriopathies are the most common cause of childhood arterial ischemic stroke, and the strongest predictor of recurrent stroke, they are difficult to diagnose. We studied the role of clinical data and follow-up imaging in diagnosing cerebral and cervical arteriopathy in children with arterial ischemic stroke.MethodsVascular effects of infection in pediatric stroke, an international prospective study, enrolled 355 cases of arterial ischemic stroke (age, 29 days to 18 years) at 39 centers. A neuroradiologist and stroke neurologist independently reviewed vascular imaging of the brain (mandatory for inclusion) and neck to establish a diagnosis of arteriopathy (definite, possible, or absent) in 3 steps: (1) baseline imaging alone; (2) plus clinical data; (3) plus follow-up imaging. A 4-person committee, including a second neuroradiologist and stroke neurologist, adjudicated disagreements. Using the final diagnosis as the gold standard, we calculated the sensitivity and specificity of each step.ResultsCases were aged median 7.6 years (interquartile range, 2.8-14 years); 56% boys. The majority (52%) was previously healthy; 41% had follow-up vascular imaging. Only 56 (16%) required adjudication. The gold standard diagnosis was definite arteriopathy in 127 (36%), possible in 34 (9.6%), and absent in 194 (55%). Sensitivity was 79% at step 1, 90% at step 2, and 94% at step 3; specificity was high throughout (99%, 100%, and 100%), as was agreement between reviewers (Îș=0.77, 0.81, and 0.78).ConclusionsClinical data and follow-up imaging help, yet uncertainty in the diagnosis of childhood arteriopathy remains. This presents a challenge to better understanding the mechanisms underlying these arteriopathies and designing strategies for prevention of childhood arterial ischemic stroke
    • 

    corecore